The effects of COVID-19 infection on ART pregnancies

We don’t know what the impact of COVID-19 is on pregnancy after fertility treatment. Yet the answers are of vital importance both to guide fertility services during this COVID-19 pandemic and to inform patients starting treatment about the benefits and risks of infection and vaccination. From May 2020 ESHRE began collecting data on the outcome of ART pregnancies managed during a SARS-CoV-2 infection. A first report has been published on the ESHRE website.
Only if we have more cases reported can we begin to answer the many outstanding questions about SARS-CoV-2 infection in ART pregnancies and help inform our patients. Which is why we are now calling on your help.

Call for abstracts for ESHRE 2021

Abstract submission for the virtual ESHRE 37th Annual Meeting is open. Share your latest research and clinical work at ESHRE 2021, the world’s leading event in reproductive science and medicine.

All abstracts must arrive at the ESHRE Central Office by 1 February 2021 (at 23:59:59 CET).

ESHRE STATEMENT ON COVID-19 vaccination and medically assisted reproduction

ESHRE has published a new statement on COVID-19 vaccination and assisted reproduction answering three important questions:

- Should men and women receive the COVID-19 vaccine before attempting conception?
- Should couples who received COVID-19 vaccination postpone conception, and if so, for how long?
- Should pregnant women be vaccinated?

Please check out the full statement

ESHRE good practice recommendations on the nomenclature of ectopic pregnancy

A working group of selected ESHRE members of the ESHRE Special Interest Group Implantation and Early Pregnancy and invited experts prepared recommendations on the nomenclature of ectopic pregnancy, based on a survey among members of the SIG Implantation and Early Pregnancy.

The paper "Terminology for describing normally-sited and ectopic pregnancies on ultrasound: recommendations for good practice" is now published in HRopen.